Universität zu Köln

Ansen, Sascha, Schultheis, Anne Maria, Hellmich, Martin, Zander, Thomas, Brockmann, Michael, Stoelben, Erich, Groen, Harry J. M., Timens, Wim, Buettner, Reinhard, Thomas, Roman K., Perner, Sven and Wolf, Juergen (2014). PD-L1 expression and genotype in non-small cell lung cancer (NSCLC). J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Cappuzzo, Federico, Moro-Sibilot, Denis, Gautschi, Oliver, Boleti, Ekaterini, Felip, Enriqueta, Groen, Harry J. M., Germonpre, Paul, Meldgaard, Peter ORCID: 0000-0002-5788-4463, Arriola, Edurne ORCID: 0000-0001-8960-7519, Steele, Nicola, Fox, Jesme, Schnell, Patrick, Engelsberg, Arne and Wolf, Juergen (2015). Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus. Lung Cancer, 87 (2). S. 89 - 96. CLARE: ELSEVIER IRELAND LTD. ISSN 1872-8332

Groen, Harry J. M., Akerley, Wallace L., Souquet, Pierre Jean, Laack, Eckart, Han, Ji-Youn, Smit, Egbert F., Mansfield, Aaron Scott, Garon, Edward B., Wolf, Juergen, Tan, Daniel Shao-Weng, Heist, Rebecca Suk, Waldron-Lynch, Maeve, Le Mouhaer, Sylvie, Nwana, Ngozi, Giovannini, Monica and Orlov, Sergey (2020). Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small-cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Heist, Rebecca Suk, Garon, Edward B., Tan, Daniel Shao-Weng, Groen, Harry J. M., Seto, Takashi, Smit, Egbert F., Zou, Mike R., Yang, Yiqun, Li, Ying, Chassot-Agostinho, Andrea and Wolf, Juergen (2021). Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: Results from the GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Smolonska, Joanna, Koppelman, Gerard H., Wijmenga, Cisca ORCID: 0000-0002-5635-1614, Vonk, Judith M., Zanen, Pieter, Bruinenberg, Marcel, Curjuric, Ivan, Imboden, Medea, Thun, Gian-Andri, Franke, Lude ORCID: 0000-0002-5159-8802, Probst-Hensch, Nicole M., Nuernberg, Peter, Riemersma, Roland A., van Schayck, Constant P., Loth, Daan W., Brusselle, Guy G., Stricker, Bruno H., Hofman, Albert, Uitterlinden, Andre G., Lahousse, Lies ORCID: 0000-0002-3494-4363, London, Stephanie J., Loehr, Laura R., Manichaikul, Ani, Barr, R. Graham, Donohue, Kathleen M., Rich, Stephen S., Pare, Peter, Bosse, Yohan, Hao, Ke, van den Berge, Maarten ORCID: 0000-0002-9336-7340, Groen, Harry J. M., Lammers, Jan-Willem J., Mali, Willem, Boezen, H. Marike and Postma, Dirkje S. (2014). Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis. Eur. Resp. J., 44 (4). S. 860 - 873. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003

Wolf, Juergen, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Gilloteau, Isabelle, Le Mouhaer, Sylvie, Cai, Can, Chassot-Agostinho, Andrea, Reynolds, Maria, Odom, Dawn and Heist, Rebecca Suk (2021). Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the phase II GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Wolf, Juergen, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Robeva, Anna, Le Mouhaer, Sylvie, Carbini, Mariana, Chassot-Agostinho, Andrea and Heist, Rebecca Suk (2021). Capmatinib in MET exon 14-mutated, advanced NSCLC: Updated results from the GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Wolf, Juergen, Overbeck, Tobias R., Han, Ji-Youn, Hochmair, Maximilian, de Marinis, Filippo, Ohashi, Kadoaki, Smit, Egbert F., Power, Danielle, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Waldron-Lynch, Maeve, Le Mouhaer, Sylvie, Nwana, Ngozi, Giovannini, Monica and Heist, Rebecca Suk (2020). Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Wolf, Juergen, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B., Groen, Harry J. M., Tan, Daniel S. W., Hida, Toyoaki, de Jonge, Maja, Orlov, Sergey V., Smit, Egbert F., Souquet, Pierre-Jean, Vansteenkiste, Johan, Hochmair, Maximilian, Felip, Enriqueta, Nishio, Makoto, Thomas, Michael, Ohashi, Kadoaki, Toyozawa, Ryo, Overbeck, Tobias R., de Marinis, Filippo, Kim, Tae-Min, Laack, Eckart, Robeva, Anna, Le Mouhaer, Sylvie, Waldron-Lynch, Maeve, Sankaran, Banu, Balbin, O. Alejandro, Cui, Xiaoming, Giovannini, Monica, Akimov, Mikhail and Heist, Rebecca S. (2020). Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. N. Engl. J. Med., 383 (10). S. 944 - 958. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406